California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on July 20, 2026

Jul. 20, 2026

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane

Indeterminate GlobeNewswire

Jul. 20, 2026

Pioneer Healthcare Responds to Travel Healthcare Burnout with Mentorship, Community, and 24/7 Clinician Support

Indeterminate EIN Presswire

Jul. 20, 2026

Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team 

Indeterminate GlobeNewswire

Jul. 20, 2026

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

Indeterminate GlobeNewswire

Jul. 20, 2026

Noom Launches 'Lose for Keeps' with Rebel Wilson, a New Campaign Making the Case That GLP-1 Medication and Healthy Habits Work Better Together

Indeterminate GlobeNewswire

Jul. 20, 2026

DLH to Announce Fiscal 2026 Third Quarter Financial Results

Indeterminate GlobeNewswire

Jul. 20, 2026

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

Indeterminate GlobeNewswire

Jul. 20, 2026

Big Boost to Brain Training Validity at International Alzheimer’s Meeting

Indeterminate GlobeNewswire

Jul. 20, 2026

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

Indeterminate GlobeNewswire

Jul. 20, 2026

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026

Indeterminate GlobeNewswire

Jul. 20, 2026

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

Indeterminate GlobeNewswire

Jul. 20, 2026

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Indeterminate GlobeNewswire

Jul. 20, 2026

Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026

Indeterminate GlobeNewswire

Jul. 20, 2026

Kolon TissueGene Reports Topline ACTiVION-II Phase 3 Clinical Trial Results for TissueGene-C (TG-C) Targeting Osteoarthritis (OA) of the Knee

Indeterminate GlobeNewswire

Jul. 20, 2026

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Indeterminate GlobeNewswire

Jul. 20, 2026

Canadian emergency rooms face critical challenges. This $15M gift will fuel innovation to help EDs address gaps in care.

Indeterminate GlobeNewswire

Jul. 20, 2026

Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction

Indeterminate GlobeNewswire

Jul. 20, 2026

BrainsWay Announces Strategic Investment in Radial Health, Inc.

Indeterminate GlobeNewswire

Jul. 20, 2026

Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)

Indeterminate GlobeNewswire

Jul. 20, 2026

Nouscom Selected for Oral Presentation on NOUS-209 Re-treatment and Long-Term Follow-Up in Lynch Syndrome Carriers at ESMO Congress 2026

Indeterminate GlobeNewswire